Keyphrases
Graft-versus-host Disease (GvHD)
100%
Nonmyeloablative
100%
Haploidentical Transplantation
100%
Keratinocyte Growth Factor
100%
Transplantation Model
100%
Myeloablative Conditioning
33%
Mouse Model
16%
Tumor Necrosis Factor-α
16%
Chemotherapy
16%
Survival Rate
16%
Weight Loss
16%
Conditioning Regimen
16%
Solid Tumors
16%
Plasma Citrulline
16%
Phosphate-buffered Saline
16%
Clinical Applicability
16%
Living Donor
16%
Transplantation
16%
Bone Marrow
16%
Hematological Malignancies
16%
Dermatitis
16%
Gastrointestinal Tract
16%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Cyclophosphamide
16%
Pathological Findings
16%
Haploidentical
16%
Nonmalignant
16%
Reduced Toxicity
16%
Gut Integrity
16%
Donor Availability
16%
Reduced Graft
16%
Toxicity Mitigation
16%
Donor chimerism
16%
Haploidentical Donor
16%
Low-dose Irradiation
16%
HLA-identical
16%
Non-myeloablative Transplantation
16%
Toxicity Amelioration
16%
INIS
diseases
100%
grafts
100%
host
100%
growth factors
100%
control
33%
comparative evaluations
33%
toxicity
33%
levels
16%
doses
16%
phosphates
16%
reduction
16%
tumors
16%
therapy
16%
availability
16%
malignancies
16%
animals
16%
administration
16%
losses
16%
mice
16%
stem cells
16%
chemotherapy
16%
weight
16%
injuries
16%
plasma
16%
solids
16%
tumor necrosis factor
16%
gastrointestinal tract
16%
citrulline
16%
lethals
16%
bone marrow
16%
dermatitis
16%
cyclophosphamide
16%
whole-body irradiation
16%
Medicine and Dentistry
Graft Versus Host Reaction
100%
Acute Graft Versus Host Disease
100%
Haploidentical Transplantation
100%
Keratinocyte Growth Factor
100%
Nonmyeloablative Conditioning
40%
Tumor Necrosis Factor
20%
Graft Survival
20%
Gut
20%
Survival Rate
20%
Low Drug Dose
20%
Conditioning
20%
Solid Malignant Neoplasm
20%
Hematologic Malignancy
20%
Plasma Citrulline
20%
Whole Body Radiation
20%
Gastrointestinal Tract
20%
Dermatitis
20%
Cyclophosphamide
20%
Bone Marrow Failure
20%
Phosphate Buffered Saline
20%
Allogeneic Stem Cell Transplantation
20%
Immunology and Microbiology
Keratinocyte Growth Factor
100%
Acute Graft Versus Host Disease
100%
Graft-Versus-Host Disease
100%
Conditioning
60%
Blood Plasma
20%
Tumor Necrosis Factor Alpha
20%
Survival Rate
20%
Mouse Model
20%
Gastrointestinal Tract
20%
Low Drug Dose
20%
Cyclophosphamide
20%
Dermatitis
20%
Allogeneic Stem Cell Transplantation
20%
Biochemistry, Genetics and Molecular Biology
Keratinocyte Growth Factor
100%
Conditioning
60%
Tumor Necrosis Factor
20%
Tumor Necrosis Factor Alpha
20%
Low Drug Dose
20%
Mouse Model
20%
Gastrointestinal Tract
20%
Survival Rate
20%
Cyclophosphamide
20%
Allogeneic Stem Cell Transplantation
20%
Bone Marrow Failure
20%
Phosphate Buffered Saline
20%
Blood Plasma
20%
Citrulline
20%